Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technique (Intrauterine, Intracervical, Intravaginal, Intratubal), By Component (Insemination Kits, Home Conception Devices, Others), By Source (AIH-Husband, and AID-Donor), By End User (Hospitals, Fertility Clinics & Centers, Others), By Company, By Region

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

The global artificial insemination market is grow at impressive rate through 2027. The Medical practitioners practice artificial insemination fertilization method for placing the sperm directly into a female's cervix, fallopian tube, or uterus. These practices are performed on couples or patient-facing fertility issues to achieve pregnancy, as the chances are very high. Due to technological advancement, each step is observed very minutely to reduce the chances of any complication that make this process safer for both mother and baby. According to the UN reports in 2017, the total fertility rate is predicted to decline up to 2.39 (children per woman) between the years 2020 and 2030.

Increasing infertility rate and favorable government initiatives are driving the growth of the market. Furthermore, ongoing technical advancements and increasing awareness about artificial insemination are other factors that are expected to significantly influence the growth of the market through 2027.

Increasing Infertility Rate is Driving the Market Growth

People are facing different problems and issues due to changes in the daily lifestyle of people in the modern world. It includes the food, sleep cycle, physical activities, and mental health, like stress, anxiety, and other problems. The increasing pervasiveness of the problem, consumption of unclean foods, alcohol, tobacco, and diseases like endometriosis, sterilization, cervical mucus problem, and other factors responsible for infertility led to the growth of the Artificial Insemination Market. Family planning and marriages after the 30s increased medical treatment demand for curing infertility. According to the WHO, almost 48 million couples and 186 million individuals have infertility worldwide, accounts 15% of the population. Thus, the above data indicate a positive increase in the market growth of the artificial insemination market in the upcoming year. Many insurance companies are accepting artificial insemination under medical coverage. These initiatives are helping the patient to fight infertility and driving the growth in Artificial Insemination Market.  

Peoples are the main asset for any country that can participate and support countries in economic development and growth. Hence, governments are launching various schemes to make their medical infrastructure better and broadly available to meet global benchmarks. The government and international identities make policies and induct new institutions to enhance their medical connectivity, such Assisted Reproductive Technology (ART) Regulation Bill, Nation Public Action Plan, National Family Policy, and other initiatives. As per UNSC, 84% of the country supports the policy that directly and indirectly affects the country's infertility. These policies led to increasing demand for artificial insemination in the market. All the factors mentioned above are expected to drive the growth of the artificial insemination market.

Cost Related with Artificial Insemination is Hindering the Growth

The medical cost for the artificial insemination technique in the USA is between 400 dollars to 4000 dollars approximately. The cost associated with the treatment process is still very costly for many peoples. As it is a medical process, there is a chance of negative pregnancy results after the process is completed. In these cases, patients’ losses all their money without any satisfactory result. Many financial institutions are providing medical insurance coverage for artificial insemination. Apart from these supply chain disturbances, the lack of unskilled labor is another factor responsible for restraining market growth.

Increase in Deliberate Collaboration and Product Launch

Growth in market share of the artificial insemination market is propelling the launch of new products and strategic partnerships between two organizations. These scenarios will help both organizations to use their competencies and increase the revenue share. As the market is growing, market players are investing aggressively, leading to technological advancements, and extending their niche market.

In 2021, Vitrolife AB acquired Igenomix S.L to help them extend their product line in existing and target new market segments using their strong competencies.

In 2020, Genea Limited collaborated with Hamilton's throne partner. This step allowed both companies to make good relationships with the customer in USA and Canada and grow the Genea Biomedx operations and customer support.


DOWNLOAD FREE SAMPLE REPORT

Market Segmentation

The global artificial insemination market is segmented based on technique, component, source, and end-user. Based on technique, market is divided into intrauterine, intracervical, intravaginal, and intratubal. Based on component type, market is divided into Insemination Kits, Home Conception Devices, and Others. Based on source type, market is split into AIH-Husband, and AID-Donor. Based on end user, market is divided into hospitals, fertility clinics & centers, and others, by company.

Market Players

Rocket Medical plc, Kitazato Corporation,    Vitrolife AB, Genea Limited, Rinovum Women’s Health, LLC, Pride Angel Limited, FUJIFILM Irvine Scientific, Inc., Conceivex, Inc., Surelife Pte Ltd., Biogenics Incare the major market player in Artificial Insemination Market. 

Attribute

Details

Base Year

2021

Historic Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue Forecast, Company Share, Competitive Landscape, Growth Factors, and Trends

Segments covered

·         Technique

·         By Component

·         By Source

·         By End User

Regional scope

North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Belgium; Russia; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; Turkey; Egypt.

Key companies profiled

Rocket Medical plc, Kitazato Corporation,     Vitrolife AB, Genea Limited, Rinovum Women’s Health, LLC, Pride Angel Limited, FUJIFILM Irvine Scientific, Inc., Conceivex, Inc., Surelife Pte Ltd., Biogenics Inc

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global Artificial Insemination Market has been segmented into following categories, in addition to the industry trends which have also been detailed below: 

·         Artificial Insemination Market, by as technique type:

    • Intrauterine
    • Intracervical
    • Intravaginal
    • Intratubal
    • Others
  • Artificial Insemination Market, by component type:
    • Insemination Kits
    • Home Conception Devices
    • Others
  • Artificial Insemination Market, by source type:
    • AIH-Husband
    • AID-Donor
  • Artificial Insemination Market, by end user type:
    • Hospitals
    • Fertility Clinics & Centers
    • Others
  • Medical market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Asia-Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
    • Europe & CIS
      • Germany
      • France
      • United Kingdom
      • Spain
      • Italy
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Egypt

§  Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Artificial Insemination Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Artificial Insemination Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Artificial Insemination Market

5.    Voice of Customer

6.    Global Artificial Insemination Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Technique (Intrauterine, Intracervical, Intravaginal, Intratubal)

6.2.2.    By Component (Insemination Kits, Home Conception Devices, Others)

6.2.3.    By Source (AIH-Husband v/s AID-Donor)

6.2.4.    By End User (Hospitals, Fertility Clinics & Centers, Others)

6.2.5.    By Company (2021)

6.2.6.    By Region

6.3.  Product Market Map

7.    North America Artificial Insemination Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Technique

7.2.2.    By Component

7.2.3.    By Source

7.2.4.    By End User

7.2.5.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Artificial Insemination Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Technique

7.3.1.2.2.           By Component

7.3.1.2.3.           By Source

7.3.1.2.4.           By End User

7.3.2.    Mexico Artificial Insemination Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Technique

7.3.2.2.2.           By Component

7.3.2.2.3.           By Source

7.3.2.2.4.           By End User

7.3.3.    Canada Artificial Insemination Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Technique

7.3.3.2.2.           By Component

7.3.3.2.3.           By Source

7.3.3.2.4.           By End User

8.    Europe Artificial Insemination Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Technique

8.2.2.    By Component

8.2.3.    By Source

8.2.4.    By End User

8.2.5.    By Country

8.3.  Europe: Country Analysis

8.3.1.    France Artificial Insemination Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Technique

8.3.1.2.2.           By Component

8.3.1.2.3.           By Source

8.3.1.2.4.           By End User

8.3.2.    Germany Artificial Insemination Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Technique

8.3.2.2.2.           By Component

8.3.2.2.3.           By Source

8.3.2.2.4.           By End User

8.3.3.    United Kingdom Artificial Insemination Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Technique

8.3.3.2.2.           By Component

8.3.3.2.3.           By Source

8.3.3.2.4.           By End User

8.3.4.    Italy Artificial Insemination Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Technique

8.3.4.2.2.           By Component

8.3.4.2.3.           By Source

8.3.4.2.4.           By End User

8.3.5.    Spain Artificial Insemination Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Technique

8.3.5.2.2.           By Component

8.3.5.2.3.           By Source

8.3.5.2.4.           By End User

9.    Asia-Pacific Artificial Insemination Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Technique

9.2.2.    By Component

9.2.3.    By Source

9.2.4.    By End User

9.2.5.    By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.    China Artificial Insemination Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Technique

9.3.1.2.2.           By Component

9.3.1.2.3.           By Source

9.3.1.2.4.           By End User

9.3.2.    India Artificial Insemination Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Technique

9.3.2.2.2.           By Component

9.3.2.2.3.           By Source

9.3.2.2.4.           By End User

9.3.3.    South Korea Artificial Insemination Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Technique

9.3.3.2.2.           By Component

9.3.3.2.3.           By Source

9.3.3.2.4.           By End User

9.3.4.    Japan Artificial Insemination Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           By Technique

9.3.4.2.2.           By Component

9.3.4.2.3.           By Source

9.3.4.2.4.           By End User

9.3.5.    Australia Artificial Insemination Market Outlook

9.3.5.1.        Market Size & Forecast

9.3.5.1.1.           By Value

9.3.5.2.        Market Share & Forecast

9.3.5.2.1.           By Technique

9.3.5.2.2.           By Component

9.3.5.2.3.           By Source

9.3.5.2.4.           By End User

10. South America Artificial Insemination Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Technique

10.2.2. By Component

10.2.3. By Source

10.2.4. By End User

10.2.5. By Country

10.3.             South America: Country Analysis

10.3.1. Brazil Artificial Insemination Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Technique

10.3.1.2.2.         By Component

10.3.1.2.3.         By Source

10.3.1.2.4.         By End User

10.3.2. Argentina Artificial Insemination Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Technique

10.3.2.2.2.         By Component

10.3.2.2.3.         By Source

10.3.2.2.4.         By End User

10.3.3. Colombia Artificial Insemination Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Technique

10.3.3.2.2.         By Component

10.3.3.2.3.         By Source

10.3.3.2.4.         By End User

11. Middle East and Africa Artificial Insemination Market Outlook

11.1.             Market Size & Forecast        

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Technique

11.2.2. By Component

11.2.3. By Source

11.2.4. By End User

11.2.5. By Country

11.3.             MEA: Country Analysis

11.3.1. South Africa Artificial Insemination Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Technique

11.3.1.2.2.         By Component

11.3.1.2.3.         By Source

11.3.1.2.4.         By End User

11.3.2. Saudi Arabia Artificial Insemination Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Technique

11.3.2.2.2.         By Component

11.3.2.2.3.         By Source

11.3.2.2.4.         By End User

11.3.3. UAE Artificial Insemination Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Technique

11.3.3.2.2.         By Component

11.3.3.2.3.         By Source

11.3.3.2.4.         By End User

11.3.4. Egypt Artificial Insemination Market Outlook

11.3.4.1.     Market Size & Forecast

11.3.4.1.1.         By Value

11.3.4.2.     Market Share & Forecast

11.3.4.2.1.         By Technique

11.3.4.2.2.         By Component

11.3.4.2.3.         By Source

11.3.4.2.4.         By End User

11.3.5. Turkey Artificial Insemination Market Outlook

11.3.5.1.     Market Size & Forecast

11.3.5.1.1.         By Value

11.3.5.2.     Market Share & Forecast

11.3.5.2.1.         By Technique

11.3.5.2.2.         By Component

11.3.5.2.3.         By Source

11.3.5.2.4.         By End User

12. Market Dynamics

12.1.             Drivers

12.2.             Challenges

13. Market Trends & Developments

14. Competitive Landscape

14.1.             Rocket Medical plc

14.2.             Kitazato Corporation

14.3.             Vitrolife AB

14.4.             Genea Limited

14.5.             Rinovum Women’s Health, LLC

14.6.             Pride Angel Limited

14.7.             FUJIFILM Irvine Scientific, Inc.

14.8.             Conceivex, Inc.

14.9.             Surelife Pte Ltd.

14.10.          Biogenics Inc.

15. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The growing population and increasing chronic disease issues are driving the demand for the global Artificial Insemination Market.

down-arrow

Rocket Medical plc, Kitazato Corporation, Vitrolife AB, Genea Limited, Rinovum Women’s Health, LLC, Pride Angel Limited, FUJIFILM Irvine Scientific, Inc., Conceivex, Inc., Surelife Pte Ltd., Biogenics Inc.are the key players operating in the global Artificial Insemination Market.

down-arrow

Based on technique, market is divided into intrauterine, intracervical, intravaginal, and intratubal. The intrauterine segment is expected to lead the market segment in the forecast period.

down-arrow

The North American region is dominating the market and is expected to maintain its dominance over the next five years.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Artificial Insemination Market to Be Dominated by AIH-Husband Segment Through 2027

Sep, 2022

The growing infertility rate to drive the demand for Artificial Insemination Market in the forecast period, 2023-2027

Why Choose Us